STIFEL NICOLAUS & CO INC \MO\ - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 355 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2013. The put-call ratio across all filers is 0.61 and the average weighting 1.1%.

Quarter-by-quarter ownership
STIFEL NICOLAUS & CO INC \MO\ ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q3 2013$1,346,170,000
+40.3%
12,903
+15.8%
0.02%
+29.4%
Q2 2013$959,362,00011,1450.02%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2013
NameSharesValueWeighting ↓
Capital Analysts, LLC 7,350$439,309,0000.18%
GOLDMAN SACHS GROUP INC 2,996,127$179,078,0000.07%
MUFG Americas Holdings Corp 52,285$3,125,0000.06%
Zurcher Kantonalbank (Zurich Cantonalbank) 22,936$1,367,0000.05%
GOLDMAN SACHS GROUP INC 419,100$25,050,0000.01%
AQR Capital Management 35,829$2,141,0000.01%
HSBC HOLDINGS PLC 33,669$2,009,0000.01%
GOLDMAN SACHS GROUP INC 147,000$8,786,0000.00%
NOMURA HOLDINGS INC 6,000$359,0000.00%
Twin Tree Management, LP 455$27,0000.00%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders